According to recent data, high levels of tumor PD-L1 expression usually indicate an enhanced likelihood that a patient will benefit from treatment with PD-1/PD-L1 inhibitors, [2, 5, 6] nonetheless, a subset of patients negative for PD-L1 expression can still respond to treatment [1, 3]. Here, CD274 is linked to neoplasm.